Codexis Generics focuses on development and commercialization of active pharmaceutical ingredients Close
Active Pharmaceutical Ingredient (API)The pharmaceutically active substance (molecule) in a drug.(APIs) and pharmaceutical intermediates using its proprietary biocatalytic chemical processes. Our generic products portfolio concentrates on generic APIs and intermediates in high-growth markets and includes products for infectious disease, cardiovascular, and CNS indications. Among the generic intermediates currently available from Codexis is ATS-8, the key chemical intermediate CloseIntermediateA material produced during the synthesis of an API. An intermediate undergoes molecular change or purification before it becomes the API. Each reaction step may create one or more intermediates. in atorvastatin, the active ingredient in the world’s largest selling drug for lowering cholesterol. Codexis collaborates with world leading manufacturers in the development and commercial-scale manufacture of generic APIs and intermediates.
Codexis collaborates with world-leading manufacturers in the development and commercial-scale manufacture of generic APIs and intermediates.
Contact Codexis Generics
When you work with Codexis Generics, you get the support that you expect from one of the world’s leading innovators in biocatalytic production of APIs and intermediates. At Codexis, we take a great deal of pride in providing our customers and partners with responsive service and expert technical assistance. For more information on Codexis Generics, e-mail generics@codexis.com.